Tenders/Clostridium botulinum (Onabotulinum) Toxin Type A 100 E. Powder for preparation of an injection solution (medical indication) pcs
Awarded🇩🇪GermanySupplies

Clostridium botulinum (Onabotulinum) Toxin Type A 100 E. Powder for preparation of an injection solution (medical indication) pcs

Auto-translated from German
Original title: Clostridium botulinum (Onabotulinum) Toxin Typ A 100 E. Pulver zur Herstellung einer Injektionslösung (medizinische Indikation) St
PBMG eG
Published: May 13, 2026
Updated: Jun 23, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

PBMG eG Germany: Clostridium botulinum (Onabotulinum) Toxin Typ A 100 E. Supplies contract awarded, healthcare. Awarded to Abacus Medicine AS, May 2026.

This is a supplies contract in the health and medical services sector. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from German

Procurement of medicines: Clostridium botulinum (Onabotulinum) Toxin Type A 100 E. Powder for preparation of an injection solution (medical indication) pcs

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on May 13, 2026. Last refreshed 12 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About PBMG eG

PBMG eG has issued 29 procurement notices on BidsFactory, including 4 currently open and 24 awarded contracts. Activity concentrates in Health & Medical and General Supplies & Services. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: July 1, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Abacus Medicine AS. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by PBMG eG in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
German

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

PBMG eG
🇩🇪Germany

Contact

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.

Similar Open Tenders in Germany

Open🇩🇪Germany

Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient Ganirelix (ATC code: H01CC01) within the period from 01.09.2026 to 31.08.2028 with the possibility of concluding the contract at any time during its term ("open-house model").

🏥 Health & Medical📦 General Supplies & Services
Jun 27, 2028
Open🇩🇪Germany

Open Procedure Secondary Prevention - "Movement and Nutrition" Offer

🏥 Health & Medical
Oct 5, 2026
Open🇩🇪Germany

Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) of the Social Code Book V on medicinal products containing the active ingredient Denosumab Xgeva (WHO ATC code: M05BX04)

🏥 Health & Medical📦 General Supplies & Services
Jul 31, 2027
Open🇩🇪Germany

Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for medicinal products with the active substance combination of formoterol and beclometasone, excluding metered-dose inhalers with a strength of 100µg/6µg (ATC code: R03AK08) within the period from 01.09.2026 to 31.08.2028 with the possibility of concluding the contract at any time during its term ("open-house model").

🏥 Health & Medical📦 General Supplies & Services
Jun 27, 2028
Open🇩🇪Germany

Open Procedure Secondary Prevention - Offer "Mentally Healthy

🏥 Health & Medical
Oct 5, 2026
Open🇩🇪Germany

Brivaracetam (N03AX23)

🏥 Health & Medical📦 General Supplies & Services
Dec 31, 2026